Central nervous system prophylaxis in haematological malignancies

Internal Medicine Journal

Volumn 32, Issue 5-6, 2002, Pages 252-258

  Wellwood, J ^a   Taylor, K ^a  

^a MATER HOSPITAL   (Australia)

Author keywords

Central nervous system; Cranial irradiation; High dose methotrexate; Leukaemia; Lymphoma; Prophylaxis

Indexed keywords

CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MEGADOSE; HUMAN; LEUKEMIA; LYMPHATIC LEUKEMIA; MULTIPLE MYELOMA; NEUROTOXICITY; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKULL IRRADIATION; TREATMENT OUTCOME;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CHILD; CRANIAL IRRADIATION; CYTARABINE; HUMANS; INJECTIONS, SPINAL; LEUKEMIA; LYMPHOMA; METHOTREXATE; RISK FACTORS;

EID: 0036379564     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00214.x     Document Type: Review

References (52)

1. Sheehan T, Cuthbert RJG, Parker AC. Central nervous system involvement in haematological malignancies. Clin Lab Haematol 1989; 11: 331-8.
2. Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Central nervous system involvement in patients with diffuse aggressive non-Hodgkins lymphoma. Am J Clin Oncol 1991; 14: 478-82.
3. Bleyer WA, Poplack DA. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 1985; 12: 131-48.
4. Gokbuget N, Hoeltzer D. Meningeosis leukaemica in adult acute lymphoblastic leukaemia. J Neurol Oncol 1998; 38: 167-80.
5. Law JP, Blom J. Adult acute leukemia frequency of central nervous system involvement in long term survivors. Cancer 1977; 40: 1304-206.
6. Stewart DJ, Keating MJ, McCredie KB et al. Natural history of central nervous system acute leukemia in adults. Cancer 1979; 47: 184-96.
7. Omura GA, Moffitt S, Vogler WR, Salter MM. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophyalxis. Blood 1980; 55: 197-204.
8. Moe PJ, Holen A. High dose methotrexate in childhood ALL. Pediatr Hematol Oncol 2000; 17: 615-22.
9. Pavlovsky S, Eppinger-Helft M, Muriel FS. Factors that influence the appearance of central nervous system leukemia. Blood 1973; 42: 935-9.
10. Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood 1988; 72: 1784-9.
11. Kantarjian HM, Smith T, Estey E et al. Prognostic significance of elevated serum beta 2- microglobulin levels in acute lymphocytic leukemia. Am J Med 1992; 93: 599-604.
12. Pui C-H, Behm FG, Downing JR et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909-15.
13. Holland JF, Glidewell O. Chemotherapy of acute lymphocytic leukemia of childhood. Cancer 1972; 30: 1480-7.
14. Pullen J, Boyett J, Shuster J et al. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia. J Clin Oncol 1993; 11: 839-49.
15. Mahoney DH Jr, Shuster JJ, Nitschke R et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate dose intravenous methotrexate and intrathecal triple therapy - a Pediatric Oncology Group study. J Clin Oncol 1998; 16: 1712-22.
16. Aur RJA, Pinkel D. Total therapy of acute lymphocytic leukemia. Prog Clin Cancer 1973; 5: 155-9.
17. Rowland JH, Glidewell OJ, Sibley RF et al. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 1984; 2: 1327-35.
18. Espy KA, Moore IM, Kaufmann PM, Kramer JH, Matthay K, Hutter JJ. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Ped Psychol 2001; 26: 1-9.
19. Nesbit ME, Sather HN, Robinson LL et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukemia: comparison of 1800 rad and 2400 rad. Lancet 1981; 1: 461-6.
20. Walter AW, Hancock ML, Pui C-H et al. Secondary brain tumours in children treated for acute lymphoblastic leukemia at St Jude Children's Hospital. J Clin Oncol 1998; 16: 3761-7.
21. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioural sequelae of cranial irradiation in adults. a review of radiation-induced encephalopathy. J Clin Oncol 1994; 12: 627-42.
22. Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975; 35: 306-9.
23. Kantarjian HM, O'Brien S, Smith T et al. Results of treatment with Hyper- CVAD, a dose intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547-61.
24. Gokbuget N, Hoelzer D. High-dose methotrexate in the treatment of adult lymphoblastic leukemia. Ann Hematol 1996; 72: 194-201.
25. Bernard S, Etienne MC, Fischel JL, Formento P, Milano G. Critical factors for the reversal of methotrexate cytotoxicity by folinic acid. Br J Cancer 1991; 63: 303-7.
26. Morra E, Lazzarino M, Inveradi D et al. Systemic high dose Ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkins lymphoma. J Clin Oncol 1986; 4: 1207-11.
27. Brown RT, Madan-Swain A, Walco GA et al. Cognitive and late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Ped Psychol 1998; 23: 333-40.
28. Jones B, Freeman AI, Shuster JJ et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991; 19: 269-75.
29. Dibenedetto S, DiCataldo A, Ragussa R. Levels of L- asparagine in the CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia. J Clin Oncol 1995; 13: 339.
30. Kamps WA, Bokkerink JP, Hahlen K et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-91). Blood 1999; 94: 1226-36.
31. Kantarjian HM, Walters RS, Keating MJ. Results of the vincristine, doxorubicin and dexamethasone regimen in adults with standard and high-risk acute lymphocytic leukemia. J Clin Oncol 1990; 8: 994-1004.
32. Weirnik PH, Dutcher JP, Paietta E et al. Long term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia 1993; 7: 1236-41.
33. Hoelzer D, Gokbuget N. Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol 2000; 36: 49-58.
34. Pippard MJ, Callender ST, Sheldon PWE. Infiltration of the central nervous system in adult acute myeloid leukemia. Br Med J 1979; 1: 227-9.
35. Cuttner J, Conjalka MS, Reilly M. Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med 1980; 69: 555-8.
36. Creutzig U, Ritter J, Zimmermann M, Schellong G. Does cranial irradiation reduce the risk of bone marrow relapse in acute myelogenous leukemia? Unexpected results of the childhood acute myelogenous leukemia study BFM-87. J Clin Oncol 1993; 11: 279-86.
37. Keidan AJ, Jan-Mohamed R, Leyland MJ, Franklin IM. AML autografting - is there a need for CNS prophylaxis? Clin Lab Haematol 1988; 10: 481-3.
38. Keldsen N, Michalski W, Bentzen SM, Hansen KB, Thorling K. Risk factors for central nervous system involvement in non-Hodgkins lymphoma. Acta Oncol 1996; 35: 703-8.
39. Horak ID, Kremer AB, Magrath IT. Management of histologically aggressive lymphomas with a high risk of CNS disease. Baillieres Clin Haematol 1996; 9: 707-27.
40. Cherlow JM, Steinherz PG, Sather HN et al. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Children's Cancer Group. Int J Radiat Oncol Biol Phys 1993; 27: 1001-9.
41. Haioun C, Besson C, Lepage E et al. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkins lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Ann Oncol 2000; 11: 685-90.
42. Litman JP, Cabanillas F, Smith TL, Bodey GP, Freirich EJ. Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood 1979; 54: 1249-57.
43. Von Besien K, Ha CS, Murphy S et al. Risk factors, treatment and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 1998; 91: 1178-84.
44. Bishop PC, Wilson WH, Pearson D, Janik J, Jaffe ES, Elwood PC. CNS involvement in primary mediastinal large B cell lymphoma. J Clin Oncol 1999; 17: 2479-85.
45. Tomita N, Kodama F, Sakai R et al. Predictive factors for central nervous system involvement in non-Hodgkins lymphoma: significance of very high serum LDH concentrations. Leuk Lymphoma 2000; 38: 335-43.
46. Shipp MA, Harrington DP, Anderson JR et al. A predictive model for aggressive non-Hodgkins lymphoma. N Engl J Med 1993; 329: 987-94.
47. Bos GMJ, van Putten WLJ, van der Holt B et al. For which patients with aggressive non-Hodgkins lymphoma is prophylaxis for central nervous system disease mandatory? Ann Oncol 1998; 9: 191-4.
48. Perez-Soler R, Smith TL, Cabanillas F. Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type. Cancer 1986; 57: 971-7.
49. Bruyn GAW, Zwetsloot CP, van Nieuwkoop JA, Ottolander GJ, Padberg GW. Cranial nerve palsy as the presenting feature of secondary plasma cell leukaemia. Cancer 1987; 60: 906-9.
50. Ingletto D, Compagnucci M, Grillo LR, Montuoro A. Primary plasmacytoma of the testis. A case report. Tumori 1998; 84: 75-7.
51. Veinstein A, Brizard A, Randriamalala E, Babin P, Preud'homme JL, Guilhot F. Central nervous system relapses after autologous stem cell transplantation for myeloma. Report of two cases. Haematol Cell Ther 1997; 39: 327-30.
52. Wellwood J, Taylor K, Weight S et al. Relapsed plasma cell leukaemia presenting with aggressive exteamedullany plasmacytomas in the meniges and testis - a missed opportunity for induction CNS prophylaxis. Leukaemia and Lymphoma 2002 (in press).